ArticleBMC women's health2025
Sexual activity and functioning after breast cancer treatment: perspectives on the importance of pleasure from a radiotherapy cohort.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Patterns of sexual dysfunction among breast cancer survivors five years after diagnosis: a latent class analysis of the French VICAN5 study.Journal of cancer survivorship : research and practice · 2026Article
- The EORTC updated breast cancer quality of life questionnaire EORTC QLQ-BR42: A psychometric study with Spanish patients.BMC cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundBreast cancer affects millions of women and while treatment can be lifesaving, it also has numerous side effects, including those related to sexual function, which often impact the ability to experience pleasure from sex. This study aimed to understand how breast cancer survivors define sexual activity, identify important aspects, and ascertain perceived impacts of treatment on sexual activity and function, particularly related to pleasure.
methodsSemi-structured interviews were conducted with women who were breast cancer survivors at least one-year post-radiation. Priority populations were oversampled (racial/ethnic/sexual/gender minorities, those aged over 65 or under 45). The sample included 23 participants: 11 Non-Hispanic White, 8 Non-Hispanic Black, 2 Non-Hispanic Asian, 2 Hispanic/Latinx, and 1 transgender participant. Mean age was 58.6 years (range 34-77, SD = 12.2).
resultsFour themes were identified: 1) Sexual activity is defined broadly, and intimacy and pleasure are key. Participants defined sex in broad terms and highlighted the importance of being close with partners and pleasure. Sex was important across the lifespan and among participants from different backgrounds, 2) Few anticipated sexual side effects: Although treatment side effects were common, few expected them, 3) Clinician communication is lacking or mistimed: Participants did not remember conversations about potential side effects because they did not happen, or they were not in a mental space to process them, 4) Sexual health side effects are plentiful and for many, long-lasting. Changes to breast sensitivity and ability to achieve orgasm were reported. Breast cancer survivors conceptualized sexual activity through a broad lens and highlighted the importance of sex, particularly pleasure and intimacy. Participants reported a variety of negative effects from treatment that impacted pleasure, and patient/clinician communication on sexual health was perceived to be lacking.
conclusionClinicians may improve survivors' quality of life by acknowledging clinical origins of sexual dysfunction, prioritizing pleasure and intimacy in the development of interventions to prevent or mitigate sexual side effects and fostering open communication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.